UpFront
-
Forbes India 30 Under 30: All about intensity and passion of growing better
The Forbes India 30 under 30 class of 2025 comprises achievers from 19 categories, from enterprise technology and clean energy to agritech and design. This issue is about the roaring 20s—the time to, as the song goes, 'set the world on fire and 'burn brighter than the sun'
-
Budget 2025: Key changes needed in the PLI Scheme
Experts say budget should focus on expanding the scheme to encompass green energy, advanced textiles, space tech and electronics components among others, as well as extend support to labour-intensive sectors for job creation
-
Budget 2025: What will be the government's priorities to boost progressive growth?
How will government tackle key issues like weak consumption demand, depreciating currency, low government spendings and tepid private investments through policy intervention in Budget 2025?
-
Budget 2025: Focus on growth and fiscal consolidation
The street expects Finance Minister Nirmala Sitharaman to walk the path of fiscal prudence as she readies to deliver her eighth consecutive Union Budget on February 1
-
Why brands are flocking to running
The exponential growth of running enthusiasts—going up from 10,000-odd registered runners in 2004 to 2.5 million now—has given brands an avenue to engage with a captive audience
-
Swiggy: Eyeing the gravy train
Swiggy's challenge is to cost-effectively retain customers and delivery partners and attract new ones. Can Swiggy pull it off?
-
Will 2025 be a reality check for stock markets in India?
The year 2025 could be a reality check for India, which has been in slowdown mode with foreign investors dumping stocks. It could, however, benefit from tariff-related cross-currents between the US and China
-
Digital Data Protection Rules 2025: Here's what needs to change
Despite the sixteen-and-a-half-month wait for these rules, experts have criticised the rules for being vague and lacking clarity
-
Mankind Pharma's formula for success
Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty products and a segregated OTC business to emerge as the fourth largest pharma player in the country
-
Navigating the hushed territory of egg freezing in India
Despite the increased uptake and social acceptance in metros, challenges remain in smaller cities and towns
